Document is current
Any future updates will be listed below
-
Authors
Driezen, Pete
Gravely, Shannon
Kasza, Karin A.
Thompson, Mary E.
Cummings, K. Michael
Hyland, Andrew
Fong, Geoffrey T.
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (R01 CA100362, P01 CA200512, R01 CA100362, R01 CA100362, R01 CA100362, R01 CA100362)
Robert Wood Johnson Foundation (045734, 045734, 045734, 045734, 045734)
Canadian Institutes of Health Research (MOP-57897, FDN-148477, MOP-57897, MOP-57897)
Ontario Institute for Cancer Research
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 31 March 2024
First Online: 9 April 2024
Declarations
:
: All respondents participating in the ITC 4 C and ITC 4CV surveys provided informed consent prior to completing a survey. The survey protocols and all materials, including the survey questionnaires of ITC Four Country Surveys of 2002–2015, were cleared for ethics by Research Ethics Board, University of Waterloo, Canada (REB#10556, REB#13978, REB#17469; Roswell Park Comprehensive Cancer Center, US (IRB NT 02–20). The survey protocols and all materials, including the survey questionnaires of ITC Four Country Smoking and Vaping Surveys of 2016–2020, were cleared for ethics by Research Ethics Board, University of Waterloo, Canada (REB#20803/30570) Roswell Park Comprehensive Cancer Center, US (IRB NT 02–20) and ethics clearance from Medical University of South Carolina was waived due to minimal risk. Ethics clearance for conducting secondary data analysis using ITC data was received from the Research Ethics Board, University of Waterloo, Canada (REB#31040).
: Not applicable.
: GTF has served as a paid expert witness on behalf of governments in litigation involving the tobaccoindustry. KMC serves as an expert witness in litigation filed against cigarette manufacturers.
